Newsbenzinga
FDA Panel Set To Debate Moderna Flu Shot
· Published
Article summary
Moderna flu vaccine faces a key FDA advisory panel review as analysts weigh approval odds, postmarketing study costs, and growth potential.
An excerpt from the original article.
Comments —
Loading comments…